4//SEC Filing
Belsky Marc 4
Accession 0001209191-22-002475
CIK 0001645666other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:27 PM ET
Size
5.4 KB
Accession
0001209191-22-002475
Insider Transaction Report
Form 4
Belsky Marc
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-05+140,000→ 140,000 totalExercise: $14.55Exp: 2032-01-04→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001382629
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:27 PM ET
- Size
- 5.4 KB